Antula Healthcare, an independent over-the-counter (OTC) healthcare company in the Nordic markets, is the wholly owned Swedish subsidiary of HBI.
The sale to Meda will allow HBI to continue to outpace market growth in the Nordics and help Meda become a major international player in the OTC market.
HBI chairman Barry Clare said Antula’s management team has achieved sustainable revenue growth through innovative marketing, line extensions, and new product launches.
"We are particularly proud of their accomplishment in developing and building their own flagship product SB-12, a medicated mouthwash, into a SEK200m product in the Nordic market," Clare said.